spacer
spacer

PDBsum entry 6api

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Proteinase inhibitor PDB id
6api
Contents
Protein chains
339 a.a.
35 a.a.
Ligands
GTH
NAG-NAG-MAN-MAN-
NAG-MAN
NAG-NAG
NAG
Waters ×49

References listed in PDB file
Key reference
Title Human alpha 1-Proteinase inhibitor. Crystal structure analysis of two crystal modifications, Molecular model and preliminary analysis of the implications for function.
Authors H.Loebermann, R.Tokuoka, J.Deisenhofer, R.Huber.
Ref. J Mol Biol, 1984, 177, 531-557. [DOI no: 10.1016/0022-2836(84)90298-5]
PubMed id 6332197
Abstract
Two closely related crystal structures of alpha 1-proteinase inhibitor modified at the reactive site peptide bond Met358--Ser359 have been analysed. The crystal structure has been obtained from diffraction data at 3 A resolution, with phases originally from isomorphous replacement. The electron density map was substantially improved by cyclic averaging of the electron densities of the two crystal forms and allowed the chain to be traced in terms of the known chemical amino acid sequence. Energy restrained crystallographic refinement was initiated and resulted in conventional R-values of 0.251 for the tetragonal crystal form (6 to 3 A resolution) and 0.247 for the hexagonal crystal form (6 to 3.2 A resolution). The polypeptide chain is almost completely arranged in well-defined secondary structural elements: three beta-sheets and eight alpha-helices. The helices are preferentially formed by the first 150 residues. They are in proximity underneath sheet A. The chain ends Met358 and Ser359 of the nicked species are arranged in strands on opposite ends of the molecule indicating a major structural rearrangement upon modification of the intact inhibitor. It is suggested that the Met358 strand is in a different conformation removed from sheet A and approaches Ser359 in the intact inhibitor species. Glu342, which is exchanged by a lysine in the Z-variant is in a strategic position for such a rearrangement. The three carbohydrate chains of alpha 1-proteinase inhibitor have partly defined electron density close to their attachment sites at asparagine residues. The anti-thrombin and ovalbumin amino acid sequences can be accommodated in the alpha 1 inhibitor molecular structure. The intron-exon junctions of the ovalbumin and the alpha 1-proteinase inhibitor gene are all in surface loops of the mature protein.
Figure 4.
IG. 4. (a) and (b) Stereo diagram of the arrangement of sheets A to C. (Figs 3(b), 3(c), 4(b) and 5 were produced with a program by Lesk & Hardman (1982).)
Figure 6.
FIG. 6. Stereo diagrams of the distribution of (a) apolar, (1)) acidic and (c) basic residues in cc,-proteinase inhibitor.
The above figures are reprinted by permission from Elsevier: J Mol Biol (1984, 177, 531-557) copyright 1984.
Secondary reference #1
Title Interaction of human alpha 1-Proteinase inhibitor with chymotrypsinogen a and crystallization of a proteolytically modified alpha 1-Proteinase inhibitor.
Authors H.Löbermann, F.Lottspeich, W.Bode, R.Huber.
Ref. Hoppe Seylers Z Physiol Chem, 1982, 363, 1377-1388.
PubMed id 6983488
Abstract
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer